Natco Pharma is planning to expand its production unit in Vaikadu village in Manali near Chennai in Tamil Nadu. The project involves expanding bulk drug unit to produce Chlorambucil (0.009 tpa), Doxorubicin Hydrochloride (0.048 tpa), Fulvestrant (0.049 tpa), Melphalan (0.009 tpa), Bendamustine HCl (0.30 tpa), Bortezomib (0.01 tpa), Decetabine (0.12 tpa), Everolimus (0.03 tpa), Temsilrolimus (0.01 tpa) and others. The project cost is estimated at Rs. 868.2 million.
Company Profile : Natco Pharma Ltd
Leave a Reply